ADVERTISEMENT

404

Not Found

Is this what you were looking for?

templates trackable display news jsp

How to track a stem cell
Andrea Gawrylewski | Apr 30, 2008 | 2 min read
Before therapies using human embryonic stem cells can be approved by the Food and Drug Administration, researchers will have to answer one key question: where do the cells go when they are injected into the patient? During an FDA meeting earlier this linkurl:month;http://www.the-scientist.com/templates/trackable/display/blog.jsp?type=blog&o_url=blog/display/54544&id=54544 on the safety of embryonic stem cell therapies, the agency grappled with the issues of tracking stem cells in vivo. Regardl
News in a nutshell
Alison McCook | May 2, 2010 | 2 min read
RIP, sickle-cell scientistHelen M. Ranney, the first woman to head a department of medicine at a U.S. medical school, died last month at age 89. Ranney was a pioneer in the field of genetics, studying the inheritance of sickle cell disease in the early 1950s, when scientists knew little about DNA. To identify carriers of the sickle cell gene, she adapted gel electrophoresis to quickly and easily separate cells with normal hemoglobin from distorted, sickle-shaped cells, since adult carriers conta
Obama to lift stem cell ban?
Andrea Gawrylewski | Nov 9, 2008 | 1 min read
US President-elect Barack Obama is already considering a lift on the current restrictions on embryonic stem cell research, according to a member of Obama's transition team. Yesterday, John Podesta, one of the senior members of Obama's transition team and the previous chief of staff for Bill Clinton, told Fox News Sunday that the transition team is already considering lifting current linkurl:limits on stem cell research,;http://www.the-scientist.com/article/display/53224/ and how Obama can lift
Can publishers and NIH make OA work?
Andrea Gawrylewski | Mar 6, 2008 | 2 min read
The April 7 deadline is rapidly approaching for submitting all publications based on NIH-funded work to PubMed Central. But some publishers are still grumbling about how the NIH plans to implement the public access mandate, which was put in place in linkurl:January.;http://www.the-scientist.com/blog/display/54028/ linkurl:Last month,;http://www.the-scientist.com/blog/display/54372/ Pennsylvania Senator Arlen Specter asked NIH director Elias Zerhouni in a letter whether the NIH had adequately di
Big tobacco stubs out research money
Andrea Gawrylewski | Feb 28, 2008 | 1 min read
Big tobacco is pulling its money out of academic research -- kind of. Tobacco company Philip Morris told researchers in September of last year that it was ending its controversial extramural research program, Science linkurl:reported;http://www.sciencemag.org/cgi/content/summary/319/5867/1173a today. But some funding from the company remains. The news of the ended sponsorship spread this month when University of California President Robert Dynes noted in a February 5 letter to the UC chancell
The Scientist Daily
The Scientist | May 11, 2006 | 1 min read
The Scientist Daily Get the latest science news and information from The Scientist delivered to your e-mail inbox every day.New to The Scientist? To get the Daily Email you'll need to go through a quick and easy registration process. To get started with your registration, click hereAlready have an account with The Scientist? Log in to your account and edit your e-mail preferences to sign up for The Scientist Daily. While you're there
Bluesens
Bluesens | Jan 12, 2009 | 2 min read
Bluesens Gas analyser for bioprocessing BCpreFerm for measuring CO2 and O2 on flasks and fermenters. lueSens gas sensor GmbH develops and markets FDA compliant PAT (process analytical technology) conform sensors for the detection and analysis of many gases, including CO2 and O2. Founded in 2001 as a specialist for gas analysis in bioprocessing, Blue- Sens is now established as the market leader, supplying sensors worldwide. Applications
It's all about Cells
Miltenyi Biotec | Jan 12, 2009 | 2 min read
It's all about cells Miltenyi Biotec products and services benefit the biomedical research community worldwide In 1989, a success story began in Bergisch Gladbach near Cologne: MACS® Technology was developed, an efficient and reliable method to tag and separate cells magnetically. Since then, the Miltenyi Biotec team has grown to more than 1,100 employees. They produce and market over 1,400 products for the biomedical research community worldwide,
Solutions for megatrends
Wolfgang Plischke | Jan 12, 2009 | 3 min read
Solutions for megatrends Legislation should be forward-looking for all fields of biotechnology. By Wolfgang Plischke Opinion by Wolfgang Plischke North Rhine-Westphalia is already one of Germany's most important industrial biotechnology locations. The generous funding provided by the state government for biotechnological research will be a key factor in enhancing the location's attractiveness in the future. Related Articles Pride and Pio
The Biocampus Cologne
The Biocampus Cologne | Jan 12, 2009 | 3 min read
The Biocampus Cologne Area of the future Companies need spatial perspectives to grow. Founders need a location, where the industry's knowledge is concentrated. Become a part of the industry of the future, biotechnology and life sciences, on the BioCampus Cologne, a top class location in the heart of Europe. The BioCampus Cologne is developing into a motor of innovation and one of the largest biotechnology parks in Germany. At the centre of the idea a

Run a Search

ADVERTISEMENT